These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18065104)

  • 1. Poly(epsilon-caprolactone) microparticles formed by the emulsion-evaporation method: effect of the variables of the different steps of the process on their size.
    Gutiérrez-Paúls L; González-Alvarez I; Lareo Barone M; Gil-Alegre ME; Torres-Suárez AI
    Pharmazie; 2007 Nov; 62(11):864-8. PubMed ID: 18065104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs.
    Bile J; Bolzinger MA; Vigne C; Boyron O; Valour JP; Fessi H; Chevalier Y
    Int J Pharm; 2015 Oct; 494(1):152-66. PubMed ID: 26235922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-loaded poly(epsilon-caprolactone) microparticles. I. Optimization of the preparation by (water-in-oil)-in water emulsion solvent evaporation.
    Youan BB; Benoit MA; Baras B; Gillard J
    J Microencapsul; 1999; 16(5):587-99. PubMed ID: 10499839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the use of tert-butanol/water cosolvent systems in production and freeze-drying of poly-ε-caprolactone nanoparticles.
    Zelenková T; Barresi AA; Fissore D
    J Pharm Sci; 2015 Jan; 104(1):178-90. PubMed ID: 25421731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of various technological parameters on the preparation of spray-dried poly(epsilon-caprolactone) microparticles containing a model antigen.
    Baras B; Benoit MA; Gillard J
    J Microencapsul; 2000; 17(4):485-98. PubMed ID: 10898088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone).
    Huatan H; Collett JH; Attwood D
    J Microencapsul; 1995; 12(5):557-67. PubMed ID: 8544099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of a bovine serum albumin microencapsulation process by screening design.
    Al Haushey L; Bolzinger MA; Bordes C; Gauvrit JY; Briançon S
    Int J Pharm; 2007 Nov; 344(1-2):16-25. PubMed ID: 17651928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of cyclosporine-loaded poly-sigma-caprolactone nanoparticles.
    Molpeceres J; Aberturas MR; Chacón M; Berges L; Guzmán M
    J Microencapsul; 1997; 14(6):777-87. PubMed ID: 9394259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the microencapsulation of nanoparticles on the reduction of burst release.
    Hasan AS; Socha M; Lamprecht A; Ghazouani FE; Sapin A; Hoffman M; Maincent P; Ubrich N
    Int J Pharm; 2007 Nov; 344(1-2):53-61. PubMed ID: 17643878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability.
    Nihant N; Schugens C; Grandfils C; Jérôme R; Teyssié P
    Pharm Res; 1994 Oct; 11(10):1479-84. PubMed ID: 7855056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapalene-loaded poly(ε-caprolactone) microparticles: Physicochemical characterization and in vitro penetration by photoacoustic spectroscopy.
    Nadal JM; Dos Anjos Camargo G; Novatski A; Macenhan WR; Dias DT; Barboza FM; Lyra A; Roik JR; Padilha de Paula J; Somer A; Farago PV
    PLoS One; 2019; 14(3):e0213625. PubMed ID: 30897170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of water-containing polymer microcapsules by the complex emulsion/solvent evaporation technique. Effect of process variables on the microcapsule size distribution.
    Kentepozidou A; Kiparissides C
    J Microencapsul; 1995; 12(6):627-38. PubMed ID: 8558385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
    Karataş A; Sonakin O; Kiliçarslan M; Baykara T
    J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
    Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
    Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery.
    Benoit MA; Baras B; Gillard J
    Int J Pharm; 1999 Jul; 184(1):73-84. PubMed ID: 10425353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of starch-poly-epsilon-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications.
    Balmayor ER; Tuzlakoglu K; Azevedo HS; Reis RL
    Acta Biomater; 2009 May; 5(4):1035-45. PubMed ID: 19095509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: evaluation of different techniques for the encapsulation of pamidronate di-sodium salt.
    Weidenauer U; Bodmer D; Kissel T
    J Microencapsul; 2003; 20(4):509-24. PubMed ID: 12851051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
    Zu Y; Wu W; Zhao X; Li Y; Zhong C; Zhang Y
    Int J Pharm; 2014 Dec; 477(1-2):148-58. PubMed ID: 25455767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microparticle formation and its mechanism in single and double emulsion solvent evaporation.
    Rosca ID; Watari F; Uo M
    J Control Release; 2004 Sep; 99(2):271-80. PubMed ID: 15380636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.
    Manca ML; Mourtas S; Dracopoulos V; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):220-31. PubMed ID: 18023977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.